Mips AB (publ) MIPS
Email when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
The news check keeps the assessment current.
General analysis — not personal advice.
Add in tranches rather than chasing strength; prioritize buying on pullbacks or if upcoming Q3 commentary suggests margins can be sustained despite the settlement cost.
Q2 confirms scalability and strong demand while the largest legal overhang risk has been reduced through the settlement.
Sentiment has strengthened to very positive after a clear Q2 beat and reduced legal uncertainty following the settlement; short-term there is some concern over the one-off effect in Q3 and volatility after the share price surge.
BUY is the call. Positive is the market mood. Low risk means less can go wrong.
Latest change
- 1 Aug 2026 — The report beat expectations driven by strong organic growth and margin expansion following customer inventory adjustments.
The full analysis is open. Follow the company free for the full change history — and email next time the picture changes.
Show all changes (7) — follow the company freeAbout the company
Mips AB develops and licenses rotational impact protection technology (Mips BPS) integrated into helmets across sports, motorcycle and professional safety. The company is profitable with a scalable ingredient-brand model, but faces margin pressure, FX and trade/tariff uncertainty. The Koroyd acquisition broadens the technology portfolio and could support growth through 2026.
Bull case
Q2 shows high organic growth and margin expansion that strengthens the growth case.
Bear case
One-off cost from the settlement and risk of margin pressure may affect the Q3 result.
Why this signal
Q2 confirms scalability and strong demand while the largest legal overhang risk has been reduced through the settlement.
Recent news
The share has traded sideways between approximately 368 and 392 SEK during the first half of September. Mips was highlighted in media as one of the few companies with unanimous buy recommendations from all covering analysts.